Exacerbation of Crohn's Disease Following Exposure to Anti-OX40 Monoclonal Antibody Therapy.
Saved in:
| Title: | Exacerbation of Crohn's Disease Following Exposure to Anti-OX40 Monoclonal Antibody Therapy. |
|---|---|
| Authors: | MacKay S; Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada., Alhaidari S; Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada., Cooper J; Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada., Halloran B; Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada., Gozdzik M; Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. |
| Source: | ACG case reports journal [ACG Case Rep J] 2025 Aug 13; Vol. 12 (8), pp. e01810. Date of Electronic Publication: 2025 Aug 13 (Print Publication: 2025). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 101638398 Publication Model: eCollection Cited Medium: Print ISSN: 2326-3253 (Print) Linking ISSN: 23263253 NLM ISO Abbreviation: ACG Case Rep J Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2326-3253 |
|---|---|
| DOI: | 10.14309/crj.0000000000001810 |
